- CA$131.34m
- CA$2.09bn
- CA$316.37m
- 54
- 96
- 50
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 127 | 117 | 138 | 276 | 316 |
Cost of Revenue | |||||
Gross Profit | 60.1 | 62.9 | 106 | 159 | 105 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 108 | 126 | 97 | 231 | 354 |
Operating Profit | 18.9 | -8.48 | 41.1 | 45.6 | -37.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 17.9 | -8.12 | 42.1 | 44.2 | -37.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 12.7 | -8.53 | 31.2 | 30.4 | -32.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 11.6 | -7.81 | 28.8 | 28.5 | -29.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 11.6 | -7.81 | 28.8 | 28.5 | -29.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.705 | 0.721 | 1.59 | 1.47 | -0.822 |
Dividends per Share |